IGM Biosciences, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024
The Company expects to recognize full year collaboration revenue of approximately $63 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.31 USD | -4.59% | -12.98% | -.--% |
May. 09 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
May. 08 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
1st Jan change | Capi. | |
---|---|---|
-.--% | 490M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |